Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)

[1]  J. Nelson,et al.  Developing a cancer‐specific trigger tool to identify treatment‐related adverse events using administrative data , 2020, Cancer medicine.

[2]  Hardeep Singh,et al.  Failure to Rescue as a Surgical Quality Indicator: Current Concepts and Future Directions for Improving Surgical Outcomes. , 2019, Anesthesiology.

[3]  D. Morris,et al.  Intraoperative packed red blood cell transfusion (iPRBT) and PCI-normalised iPRBT rates (iPRBT/PCI ratio) negatively affect short- and long-term outcomes of patients undergoing cytoreductive surgery and intraperitoneal chemotherapy - An analysis of 880 patients. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  R. Bold,et al.  Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS‐NSQIP follow up analysis , 2019, Journal of surgical oncology.

[5]  D. Humes,et al.  A systematic review of population-based studies examining outcomes in primary retroperitoneal sarcoma surgery. , 2019, Surgical oncology.

[6]  Y. W. Kim,et al.  Association of preoperative anemia and perioperative allogenic red blood cell transfusion with oncologic outcomes in patients with nonmetastatic colorectal cancer. , 2019, Current oncology.

[7]  S. Shariat,et al.  Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis. , 2019, Urologic oncology.

[8]  J. Burcharth,et al.  The Effect of Perioperative Iron Therapy in Acute Major Non-cardiac Surgery on Allogenic Blood Transfusion and Postoperative Haemoglobin Levels: A Systematic Review and Meta-analysis , 2019, World Journal of Surgery.

[9]  J. Blay,et al.  Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG , 2019, Clinical Cancer Research.

[10]  Yanong Wang,et al.  Effect of perioperative blood transfusion on prognosis of patients with gastric cancer: a retrospective analysis of a single center database , 2018, BMC Cancer.

[11]  S. Bonvalot,et al.  Post‐relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans‐Atlantic RPS Working Group , 2017, Cancer.

[12]  S. Bonvalot,et al.  Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group , 2017, Annals of surgery.

[13]  S. Bonvalot,et al.  Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group , 2016, Annals of surgery.

[14]  Narasimhan P. Agaram,et al.  Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma , 2016, Annals of surgery.

[15]  A. Ejaz,et al.  Perioperative Blood Transfusion and the Prognosis of Pancreatic Cancer Surgery: Systematic Review and Meta-analysis , 2015, Annals of Surgical Oncology.

[16]  L. Mariani,et al.  Personalizing the Approach to Retroperitoneal Soft Tissue Sarcoma: Histology-specific Patterns of Failure and Postrelapse Outcome after Primary Extended Resection , 2015, Annals of Surgical Oncology.

[17]  J. Novak,et al.  Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana , 2005, Journal of surgical oncology.

[18]  Samuel Singer,et al.  Histologic Subtype and Margin of Resection Predict Pattern of Recurrence and Survival for Retroperitoneal Liposarcoma , 2003, Annals of surgery.

[19]  J M Woodruff,et al.  Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. , 1998, Annals of surgery.

[20]  R. Simon,et al.  Flexible regression models with cubic splines. , 1989, Statistics in medicine.

[21]  H. Eguchi,et al.  Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis , 2017, Surgery Today.

[22]  T. Group.  Erratum to: Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group , 2017 .

[23]  M. Brennan,et al.  Management of recurrent retroperitoneal sarcoma , 2014, Journal of surgical oncology.